(19)
(11) EP 1 330 520 A2

(12)

(88) Date of publication A3:
23.01.2003

(43) Date of publication:
30.07.2003 Bulletin 2003/31

(21) Application number: 01983356.5

(22) Date of filing: 31.10.2001
(51) International Patent Classification (IPC)7C12N 15/11, A61K 31/7125
(86) International application number:
PCT/CA0101/540
(87) International publication number:
WO 0203/6767 (10.05.2002 Gazette 2002/19)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 02.11.2000 US 245176 P

(71) Applicant: Inex Pharmaceuticals Corp.
Burnaby,British Columbia V6K 3S4 (CA)

(72) Inventors:
  • MADDEN, Thomas D.,c/o Inex Pharmaceuticals Corp.
    Burnaby,British Columbia V6K 3S4 (CA)
  • WEBB, Murray S.,c/o Inex Pharmaceuticals Corp.
    Burnaby,British Columbia V6K 3S4 (CA)

(74) Representative: Davies, Gregory Mark 
Urquhart-Dykes & LordAlexandra House1 Alexandra RoadWales
Swansea, Wales SA1 5ED
Swansea, Wales SA1 5ED (GB)

   


(54) THERAPEUTIC OLIGONUCLEOTIDES OF REDUCED TOXICITY